These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15468728)
21. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [TBL] [Abstract][Full Text] [Related]
22. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting]. Zhubrina ES; Ovchinnikov AG; Seredenina EM; Patrusheva IF; Blankova ZN; Kuz'mina AE; Kheĭmets GI; Ageev FT Ter Arkh; 2009; 81(11):35-40. PubMed ID: 20141011 [TBL] [Abstract][Full Text] [Related]
23. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus. Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333 [TBL] [Abstract][Full Text] [Related]
24. [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency]. Boutelant S; Lechat P; Komajda M; Isnard R; Salloum J; Gagey S; Bertholon JF; Grosgogeat Y Arch Mal Coeur Vaiss; 1992 Jun; 85(6):863-70. PubMed ID: 1358044 [TBL] [Abstract][Full Text] [Related]
25. [Influence of nebivolol on left ventricular remodeling in patients with arterial hypertension without chronic heart failure]. Khurs EM; Zinov'eva IuA; Poddubnaia AV; Smolenskaia OG Kardiologiia; 2007; 47(12):15-9. PubMed ID: 18260973 [TBL] [Abstract][Full Text] [Related]
26. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study. Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555 [TBL] [Abstract][Full Text] [Related]
27. Nebivolol: a new beta blocker on the horizon. Katira R; Chauhan A Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942 [No Abstract] [Full Text] [Related]
28. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension]. Gromnatskiĭ NI; Dius'mikeeva NB Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053 [TBL] [Abstract][Full Text] [Related]
29. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction]. Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146 [TBL] [Abstract][Full Text] [Related]
30. Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study. Hermans MP; De Coster O; Seidel L; Albert A; Van de Borne P Blood Press Suppl; 2009 Oct; 1():5-14. PubMed ID: 20050100 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary effects of nebivolol. Dal Negro R Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367 [TBL] [Abstract][Full Text] [Related]
32. Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality. Palatsi I Acta Med Scand Suppl; 1976; 599():7-84. PubMed ID: 16981325 [TBL] [Abstract][Full Text] [Related]
33. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency. Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020 [TBL] [Abstract][Full Text] [Related]
34. [Nebivolol effects on the cardiovascular system and the kidneys in pregnant and puerperal women with hypertension]. Tkacheva ON; Vertkin AL; Barabashkina AV; Vasil'eva AV; Razguliaeva NF Ter Arkh; 2006; 78(10):56-61. PubMed ID: 17180940 [TBL] [Abstract][Full Text] [Related]
35. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too]. MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284 [No Abstract] [Full Text] [Related]
36. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426 [TBL] [Abstract][Full Text] [Related]
37. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related]
38. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]